Rankings
▼
Calendar
SLDB Q4 2022 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$644M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$35M
Net Income
-$15M
EPS (Diluted)
$-1.89
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$35M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$260M
Total Liabilities
$49M
Stockholders' Equity
$212M
Cash & Equivalents
$155M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$3M
-100.0%
Gross Profit
$0
$3M
-100.0%
Operating Income
-$35M
-$19M
-85.3%
Net Income
-$15M
-$19M
+18.6%
← FY 2022
All Quarters
Q1 2023 →